Bridgefront Capital »

Vertex Pharmaceuticals Incorporated shares owned by Bridgefront Capital

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Bridgefront Capital from 13F filings

Historical chart of Bridgefront Capital investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Bridgefront Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Bridgefront Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $378k 760 496.73
2025-09-30 $354k 903 391.64
2024-12-31 $389k 967 402.70
2022-06-30 $212k 751 282.29
2021-09-30 $332k 1.8k 181.32

More positions owned by Bridgefront Capital

Colgate-Palmolive Company (CL)
Kimberly-Clark Corporation (KMB)
Tyson Foods Cl A (TSN)
Constellation Brands Cl A (STZ)
Lauder Estee Cos Cl A (EL)
Coca-Cola Company (KO)
Molson Coors Beverage CL B (TAP)
American Tower Reit (AMT)
Agree Realty Corporation (ADC)
Wells Fargo & Company (WFC)
Trane Technologies SHS (TT)
Occidental Petroleum Corporation (OXY)
Halliburton Company (HAL)
Citigroup Com New (C)
Spectrum Brands Holding (SPB)

View all positions for Bridgefront Capital

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Capital Management
State Street Corporation
Invesco
Jpmorgan Chase & Co
Geode Capital Management
Vanguard Portfolio Management
Capital Research and Management Company - Division 3
Loomis, Sayles and
Franklin Resources
Wellington Management Company
Morgan Stanley
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated